Name | methyl 3-oxo-3-[6-(trifluoromethyl)pyridin-3-yl]propanoate |
---|---|
Synonyms | MFCD01862654 |
Description | 11β-HSD1-IN-8 (compound c6a) is a 11β‑HSD1 inhibitor with an IC50 value of 2.3 μM for human 11β‑HSD1. 11β-HSD1-IN-8 can be used for the research of diabetes and cognitive decline[1]. |
---|---|
Related Catalog | |
Target |
IC50: 2.3 μM (human 11β‑HSD)[1] |
In Vitro | 11β-HSD1-IN-8 (0-50 μM) inhibits human and rat 11β‑HSD1 with IC50 values of 2.3 μM and >50 μM, respectively[1]. |
Density | 1.341g/cm3 |
---|---|
Boiling Point | 295.5ºC at 760 mmHg |
Melting Point | 60-62ºC |
Molecular Formula | C10H8F3NO3 |
Molecular Weight | 247.17100 |
Flash Point | 132.5ºC |
Exact Mass | 247.04600 |
PSA | 56.26000 |
LogP | 1.84620 |
Index of Refraction | 1.459 |
Hazard Codes | Xi |
---|---|
HS Code | 2933399090 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |